Healthcare provider profile · identity verified

Steven Eisenstein, MD

Family Practice · NORTHBROOK, IL · NPI 1447259015

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	416	121
Levothyroxine Sodium	Levothyroxine Sodium	383	77
Amlodipine Besylate	Amlodipine Besylate	288	69
Lisinopril	Lisinopril	239	57
Losartan Potassium	Losartan Potassium	232	62
Rosuvastatin Calcium	Rosuvastatin Calcium	198	59
Repaglinide	Repaglinide	160	suppressed
Simvastatin	Simvastatin	157	47
Mirtazapine	Mirtazapine	141	16
Omeprazole	Omeprazole	141	33
Metformin Hcl	Metformin Hcl	139	41
Pantoprazole Sodium	Pantoprazole Sodium	123	39
Metoprolol Succinate	Metoprolol Succinate	122	36
Duloxetine Hcl	Duloxetine Hcl	109	19
Gabapentin	Gabapentin	104	32
Tamsulosin Hcl	Tamsulosin Hcl	103	36
Alprazolam	Alprazolam	101	32
Ozempic	Semaglutide	91	15
Allopurinol	Allopurinol	86	26
Tramadol Hcl	Tramadol Hcl	81	15
Januvia	Sitagliptin Phosphate	75	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	73	14
Quetiapine Fumarate	Quetiapine Fumarate	71	suppressed
Jardiance	Empagliflozin	68	18
Clonazepam	Clonazepam	64	18
Sertraline Hcl	Sertraline Hcl	62	17
Ezetimibe	Ezetimibe	61	11
Ipratropium Bromide	Ipratropium Bromide	59	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	58	suppressed
Irbesartan	Irbesartan	58	18
Zolpidem Tartrate	Zolpidem Tartrate	57	20
Metformin Hcl Er	Metformin Hcl	54	18
Carvedilol	Carvedilol	53	15
Trazodone Hcl	Trazodone Hcl	53	14
Escitalopram Oxalate	Escitalopram Oxalate	51	17
Spironolactone	Spironolactone	51	16
Bupropion Xl	Bupropion Hcl	49	17
Memantine Hcl	Memantine Hcl	49	suppressed
Ramipril	Ramipril	47	13
Mesalamine Dr	Mesalamine	46	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	suppressed
Lorazepam	Lorazepam	43	11
Albuterol Sulfate Hfa	Albuterol Sulfate	42	15
Montelukast Sodium	Montelukast Sodium	41	12
Pravastatin Sodium	Pravastatin Sodium	41	11
Indapamide	Indapamide	39	suppressed
Chlorthalidone	Chlorthalidone	36	12
Eliquis	Apixaban	36	11
Glimepiride	Glimepiride	34	suppressed
Celecoxib	Celecoxib	32	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Budesonide Dr	Budesonide	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	18
Synthroid	Levothyroxine Sodium	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Pregabalin	Pregabalin	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Labetalol Hcl	Labetalol Hcl	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Potassium Chloride	Potassium Chloride	23	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	22	suppressed
Lactulose	Lactulose	22	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	21	suppressed
Furosemide	Furosemide	21	11
Mounjaro	Tirzepatide	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Torsemide	Torsemide	21	suppressed
Verapamil Er	Verapamil Hcl	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Bumetanide	Bumetanide	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Prednisone	Prednisone	20	14
Atenolol	Atenolol	19	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Budesonide Ec	Budesonide	19	suppressed
Finasteride	Finasteride	19	suppressed
Ketoconazole	Ketoconazole	19	14
Valacyclovir	Valacyclovir Hcl	19	suppressed
Xarelto	Rivaroxaban	18	suppressed
Minoxidil	Minoxidil	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Famotidine	Famotidine	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	14	suppressed
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Estradiol	Estradiol	13	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Valsartan	Valsartan	12	suppressed
Acebutolol Hcl	Acebutolol Hcl	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Naltrexone Hcl	Naltrexone Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error